Aimee E Vozenilek
Overview
Explore the profile of Aimee E Vozenilek including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
94
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pathology of Self-Expanding Transcatheter Aortic Bioprostheses and Hypoattenuated Leaflet Thickening
Sato Y, Torii S, Kawai K, Yahagi K, Kutyna M, Kawakami R, et al.
Circ Cardiovasc Interv
. 2025 Feb;
18(2):e014523.
PMID: 39965045
Background: Hypoattenuated leaflet thickening (HALT) is believed to reflect leaflet thrombosis; however, no systematic histological examination of HALT has ever been performed. The aim of this study was to evaluate...
2.
Konishi T, Kawakami R, Vozenilek A, Ghosh S, Xu W, Grogan A, et al.
JACC Cardiovasc Interv
. 2024 Jul;
17(14):1719-1728.
PMID: 38970581
Background: The success rate of percutaneous coronary intervention (PCI) for chronic total occlusion (CTO) is lower and the risk for complications higher compared with other non-CTO PCI. Although interventionalists focus...
3.
Mori M, Sakamoto A, Kawakami R, Guo L, Slenders L, Mosquera J, et al.
Circ Res
. 2024 Jun;
135(2):e4-e23.
PMID: 38860377
Background: Cell phenotype switching is increasingly being recognized in atherosclerosis. However, our understanding of the exact stimuli for such cellular transformations and their significance for human atherosclerosis is still evolving....
4.
Kawai K, Sakamoto A, Mokry M, Ghosh S, Kawakami R, Xu W, et al.
Arterioscler Thromb Vasc Biol
. 2023 Oct;
43(12):2333-2347.
PMID: 37881937
Background: Studies in humans and mice using the expression of an X-linked gene or lineage tracing, respectively, have suggested that clones of smooth muscle cells (SMCs) exist in human atherosclerotic...
5.
Konishi T, Kawai K, Kawakami R, Ghosh S, Vozenilek A, Bellissard A, et al.
JACC Case Rep
. 2023 Apr;
14:101826.
PMID: 37091501
Plaque rupture, plaque erosion, and COVID-19 infection can cause acute coronary syndromes (ACS). We illustrate case examples demonstrating the distinctive and characteristic pathologic findings underlying each of these various causes...
6.
Sato Y, Kawakami R, Kawai K, Konishi T, Vozenilek A, Ghosh S, et al.
J Vasc Interv Radiol
. 2023 Apr;
34(7):1166-1175.e2.
PMID: 37003576
Purpose: To evaluate the incidence of distal embolism and local vascular responses after treatment with the Kanshas drug-coated balloon (DCB) in a preclinical model. Materials And Methods: A total of...
7.
Konishi T, Ghosh S, Sato Y, Kawakami R, Kawai K, Vozenilek A, et al.
PLoS One
. 2023 Mar;
18(3):e0283840.
PMID: 37000804
Background: A deeper understanding of coronary medial thickness is important for coronary intervention because media thickness can limit the safety and effectiveness of interventional techniques. However, there is a paucity...
8.
Sakamoto A, Kawakami R, Mori M, Guo L, Paek K, Mosquera J, et al.
JCI Insight
. 2023 Jan;
8(5).
PMID: 36719758
Vascular calcification (VC) is concomitant with atherosclerosis, yet it remains uncertain why rupture-prone high-risk plaques do not typically show extensive calcification. Intraplaque hemorrhage (IPH) deposits erythrocyte-derived cholesterol, enlarging the necrotic...
9.
Kawai K, Vozenilek A, Kawakami R, Sato Y, Ghosh S, Virmani R, et al.
Expert Rev Cardiovasc Ther
. 2022 Aug;
20(9):689-705.
PMID: 35942866
Introduction: Atherosclerosis-based ischemic heart disease is still the primary cause of death throughout the world. Over the past decades there has been no significant changes in the therapeutic approaches to...
10.
Blackburn C, Schilke R, Vozenilek A, Chandran S, Bamgbose T, Finck B, et al.
Atherosclerosis
. 2021 Jul;
330:76-84.
PMID: 34256308
Background And Aims: Atherosclerosis is the most prominent underlying cause of cardiovascular disease (CVD). It is initiated by cholesterol deposition in the arterial intima, which causes macrophage recruitment and proinflammatory...